Nuevas oportunidades | 17 NOV 20

Manejo de la escabiosis

Revisión sobre nuevos tratamientos y control poblacional de la escabiosis
Autor/a: Li Jun Thean, Daniel Engelman, John Kaldor, and Andrew C. Steer  Pediatr Infect Dis J. 2019 Feb; 38 (2)
INDICE:  1. Página 1 | 2. Página 1
Página 1

1. Romani L, Steer AC, Whitfeld MJ, et al. Prevalence of scabies and impetigo worldwide: a systematic review. Lancet Infect Dis. 2015;15:960–967.

2. Engelman D, Kiang K, Chosidow O, et al; Members Of The International Alliance For The Control Of Scabies. Toward the global control of human scabies: introducing the International Alliance for the Control of Scabies. PLoS Negl Trop Dis. 2013;7:e2167.

3. World Health Organization. Report of the Tenth Meeting of the WHO Strategic and Technical Advisory Group for Neglected Tropical Diseases. WHO Publications; 2017.

4. World Health Organization. 9th NTD-STAG Global Working Group Meeting on Monitoring and Evaluation of Neglected Tropical Diseases. In: Zoerhoff K, Ramzy R, eds. World Health Organisation; 2018.

5. Karimkhani C, Colombara DV, Drucker AM, et al. The global burden of scabies: a cross-sectional analysis from the Global Burden of Disease Study 2015. Lancet Infect Dis. 2017;17:1247–1254.

6. Beeres DT, Ravensbergen SJ, Heidema A, et al. Efficacy of ivermectin mass-drug administration to control scabies in asylum seekers in the Netherlands: a retrospective cohort study between January 2014-March 2016. PLoS Negl Trop Dis. 2018;12:e0006401.

7. Mason DS, Marks M, Sokana O, et al. The prevalence of scabies and impetigo in the Solomon Islands: a population-based survey. PLoS Negl Trop Dis. 2016;10:e0004803.

8. Romani L, Koroivueta J, Steer AC, et al. Scabies and impetigo prevalence and risk factors in Fiji: a national survey. PLoS Negl Trop Dis. 2015;9:e0003452.

9. Micali G, Lacarrubba F, Verzì AE, et al. Scabies: advances in noninvasive diagnosis. PLoS Negl Trop Dis. 2016;10:e0004691.

10. Thompson MJ, Engelman D, Gholam K, et al. Systematic review of the diagnosis of scabies in therapeutic trials. Clin Exp Dermatol. 2017;42:481–487.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

CONTENIDOS RELACIONADOS
AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024